HPV9 vaccine to be added to national immunisation schedules from January 2027

The human papillomavirus 9-valent (HPV9) vaccine will be added to national immunisation schedules in Singapore starting from January 2027, according to health authorities. The vaccine will replace the HPV2 vaccine for female students who have not yet started or completed their vaccination series under the Health Promotion Board's school-based program.

The HPV9 vaccine, also known as Gardasil 9, will be included in the National Childhood Immunisation Schedule (NCIS), National Adult Immunisation Schedule (NAIS), and Subsidised Vaccine List (SVL) for females aged 9 to 26. It provides broader protection against cervical cancer by covering additional HPV types that account for 20% of cervical cancers, bringing its total coverage to approximately 90%.

Brief written by urgent.news from Channel News Asia's own syndicated text. Machine-written — may contain errors; check the original before relying on it.